SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity-Reference-Cited by-同舟云学术

SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity

Published:2001-05 Issue:1 Volume:28 Page:29-35
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Yoshikawa Hirohide,Matsubara Kenichi,Qian Geng-Sun,Jackson Peta,Groopman John D.,Manning Jasper E.,Harris Curtis C.,Herman James G.

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng0501_29.pdf

Reference44 articles.

1. Masuhara, M. et al. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239, 439–446 (1997).

2. Hilton, D.J. et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95, 114–119 (1998).

3. Starr, R. et al. A family of cytokine-inducible inhibitors of signalling. Nature 387, 917–921 (1997).

4. Endo, T.A. et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921–924 (1997).

5. Naka, T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924–929 (1997).

Cited by 472 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity;Frontiers in Immunology;2024-06-14

2. Targeted silencing of SOCS1 by DNMT1 promotes stemness of human liver cancer stem-like cells;Cancer Cell International;2024-06-12

3. One gene to rule them all – clinical perspectives of a potent suppressor of cytokine signaling – SOCS1;Frontiers in Immunology;2024-04-22

4. Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications;Cancers;2024-04-17

5. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer;Molecular and Cellular Biochemistry;2024-03-22